Pearl River Capital, LLC Charles River Laboratories International, Inc. Transaction History

Pearl River Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $322,525 - $477,791	1,580 New	1,580 $338,000
Q2 2020 Aug 10, 2020	SELL	$118.84 - $189.72 $207,732 - $331,630	-1,748 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$98.9 - $178.34 $11,076 - $19,974	112 Added 6.85%	1,748 $221,000
Q4 2019 Feb 12, 2020	BUY	$126.05 - $152.76 $206,217 - $249,915	1,636 New	1,636 $250,000
Q3 2019 Nov 08, 2019	SELL	$125.07 - $143.67 $94,302 - $108,327	-754 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$123.4 - $148.55 $14,067 - $16,934	-114 Reduced 13.13%	754 $107,000
Q1 2019 May 02, 2019	BUY	$104.82 - $146.73 $90,983 - $127,361	868 New	868 $126,000

694

52M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.